On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

John M. Lachin

ResearcherPublications, citations & collaboration network

John M. Lachin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does John M. Lachin have?

ScholarIQindexed works

John M. Lachin has 526 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does John M. Lachin have?

ScholarIQcitation count

John M. Lachin has 55,595 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of John M. Lachin?

ScholarIQh-index

John M. Lachin has an h-index of 100 in OpenAlex.

What is the i10-index of John M. Lachin?

ScholarIQi10-index

John M. Lachin has an i10-index of 288 in OpenAlex.

What is the ORCID of John M. Lachin?

ScholarIQorcid

The ORCID for John M. Lachin is on the source record.

What is the OpenAlex record for John M. Lachin?

ScholarIQopenalex

The OpenAlex for John M. Lachin is on the source record.

What are the most-cited papers on John M. Lachin?

ScholarIQmost cited works
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
New England Journal of Medicine. 201512,121 CitationsOPEN ACCESS
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Bernard Zinman
New England Journal of Medicine. 20163,655 CitationsOPEN ACCESS
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Steven E. Kahn, Steven M. Haffner, Mark Heise, William H. Herman, Rury R. Holman, Nigel C. Jones, Barbara G. Kravitz, John M. Lachin, Mark O’Neill, Bernard Zinman, Giancarlo Viberti
New England Journal of Medicine. 20062,958 Citations
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong, John B. Buse, Samuel S. Engel, Jyotsna Garg, Robert Josse, Keith D. Kaufman, Joerg Koglin, Scott Korn, John M. Lachin, Darren K. McGuire, Michael Pencina, Eberhard Standl, Peter P. Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D. Peterson, Rury R. Holman
New England Journal of Medicine. 20152,600 CitationsOPEN ACCESS
Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes
Richard F. Hamman, Rena R. Wing, Sharon L. Edelstein, John M. Lachin, George A. Bray, Linda M. Delahanty, Mary A. Hoskin, Andrea M. Kriska, Elizabeth J. Mayer‐Davis, Xavier Pi‐Sunyer, Judith G. Regensteiner, Beth Venditti, Judith Wylie‐Rosett
Diabetes Care. 20061,358 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial